Randomized trial of rTMS in traumatic brain injury: improved subjective neurobehavioral symptoms and increases in EEG delta activity-Reference-Cited by-同舟云学术

Randomized trial of rTMS in traumatic brain injury: improved subjective neurobehavioral symptoms and increases in EEG delta activity

Published:2022-02-10 Issue:5 Volume:36 Page:683-692
ISSN:0269-9052
Container-title:Brain Injury
language:en
Short-container-title:Brain Injury

Author:

Franke Laura M.¹²,Gitchel George T.²³,Perera Robert A.⁴,Hadimani Ravi L.⁵,Holloway Kathryn L.²⁶,Walker William C.¹²

Affiliation:

1. Department of Physical Medicine and Rehabilitation, Virginia Commonwealth University, Richmond, Virginia, USA

2. Hunter Holmes McGuire Veterans Affairs Medical Center, Richmond, Virginia, USA

3. Department of Biomedical Engineering, Virginia Commonwealth University, Richmond, Virginia, USA

4. Department of Biostatistics, Virginia Commonwealth University, Richmond, Virginia, USA

5. Department of Mechanical and Nuclear Engineering, Virginia Commonwealth University, Richmond, Virginia, USA

6. Department of Neurosurgery, Virginia Commonwealth University, Richmond, Virginia, USA

Funder

Virginia Department of Aging and Rehabilitative Services Commonwealth Neurotrauma Initiative Fund

Department of Biotechnology, Ministry of Science and Technology

Publisher

Informa UK Limited

Subject

Neurology (clinical),Neuroscience (miscellaneous),Developmental and Educational Psychology

Link

https://www.tandfonline.com/doi/pdf/10.1080/02699052.2022.2033845

Reference48 articles.

1. Cognitive Sequelae of Traumatic Brain Injury

2. Pharmacotherapy for Treatment of Cognitive and Neuropsychiatric Symptoms After mTBI

3. Moore SK. U.S. Regulators approve magnetic stimulation device for depression - IEEE spectrum [Internet]. IEEE Spectrum: Technology, Engineering, and Science News. 2008 cited 2021 May 28. Available from: https://spectrum.ieee.org/biomedical/devices/us-regulators-approve-magnetic-stimulation-device-for-depression

4. FDA. FDA permits marketing of transcranial magnetic stimulation for treatment of obsessive compulsive disorder [Internet]. FDA. FDA; 2020 cited 2021 May 28. Available from: https://www.fda.gov/news-events/press-announcements/fda-permits-marketing-transcranial-magnetic-stimulation-treatment-obsessive-compulsive-disorder

5. Cognitive effects of high-frequency repetitive transcranial magnetic stimulation: a systematic review

Cited by 10 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Is non-invasive neuromodulation a viable technique to improve neuroplasticity in individuals with acquired brain injury? A review;Frontiers in Human Neuroscience;2024-09-04

2. Optimizing a deep learning model for the prediction of electric field induced by transcranial magnetic stimulation for mild to moderate traumatic brain injury patients;AIP Advances;2024-01-01

3. Effectiveness of rTMS and tDCS treatment for chronic TBI symptoms: A systematic review and meta-analysis;Progress in Neuro-Psychopharmacology and Biological Psychiatry;2024-01

4. Treatment of cognitive and mood disorders secondary to traumatic brain injury by the association of bilateral occipital nerve stimulation and a combined protocol of multisite repetitive transcranial magnetic stimulation and cognitive training: A case report;Frontiers in Neurology;2023-11-07

5. Investigation of EEG Neurophysiological Relationship to TMS Response in Mild Traumatic Brain Injury Patients;IEEE Transactions on Magnetics;2023-11